Experimental Cancer Therapy Shows Over 70% Patient Success in Global Clinical Trials
New York, NY (December 10, 2022) — A new therapy that forces the immune system to kill bone marrow cancer cells has been successful in up to 73% of patients in two clinical trials, according to researchers from the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. The therapy, known as …
Experimental Cancer Therapy Shows Over 70% Patient Success in Global Clinical Trials Read More »
